What is Halozyme Therapeutics's gross profit?

Halozyme Therapeutics (HALO) reported gross profit of $297.47M in Q1 2026.

How has Halozyme Therapeutics's gross profit changed year-over-year?

Halozyme Therapeutics's gross profit increased by 37.4% year-over-year, from $216.46M to $297.47M.

What is the long-term trend for Halozyme Therapeutics's gross profit?

Over 4 years (2021 to 2025), Halozyme Therapeutics's gross profit has grown at a 34.0% compound annual growth rate (CAGR), from $361.9M to $1.17B.

Halozyme Therapeutics HALO Gross Profit

Gross Profit at other companies

West Pharmaceutical ServicesWST

$296.4M+27.8%

AbbVieABBV

$10.78B+15.4%

BridgeBio PharmaBBIO

——

AptarGroupATR

——

AlkermesALKS

——

United TherapeuticsUTHR

——

Other financials

Income statement

See full

Revenue$376.7M+42.2%

Operating income$184.5M+30.4%

Net income$150.0M+27.1%

EPS (diluted)$1.22+31.2%

Balance sheet

See full

Cash & equivalents$312.0M+76.9%

Total debt$2.2B+41.7%

Total equity$219.6M-54.5%

Total assets$2.7B+21.7%

Cash flow

See full

Operating cash flow$180.1M+16.8%

CapEx$3.7M+294%

Free cash flow$176.3M+15.0%

Valuation

See full

Market cap$8.13B-2.9%

Enterprise value$10B+3.0%

P/E13.4×-3.8×

P/S5.4×-2.3×

Profitability

See full

Gross margin82.8%-0.7pp

Operating margin59.3%+9.0pp

Net margin47.9%+6.5pp

FCF margin44.3%-1.5pp

Returns & leverage

See full

Return on equity124.5%+12.7pp

Debt / equity9.9×+6.7×

Current ratio2.8×-5.6×

Where this comes from

Calculated from Halozyme Therapeutics’s reported figures.

$376.7Mtotal revenue−$79.2Mtotal cost of revenue=$297.47M

The official record: Halozyme Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Halozyme Therapeutics's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Halozyme Therapeutics's gross profit?: Halozyme Therapeutics (HALO) reported gross profit of $297.47M in Q1 2026.
How has Halozyme Therapeutics's gross profit changed year-over-year?: Halozyme Therapeutics's gross profit increased by 37.4% year-over-year, from $216.46M to $297.47M.
What is the long-term trend for Halozyme Therapeutics's gross profit?: Over 4 years (2021 to 2025), Halozyme Therapeutics's gross profit has grown at a 34.0% compound annual growth rate (CAGR), from $361.9M to $1.17B.